首页> 外文会议>Medical Applications of Lasers >Transurethral laser coagulation of the prostate
【24h】

Transurethral laser coagulation of the prostate

机译:经尿道前列腺电凝术

获取原文
获取原文并翻译 | 示例

摘要

Abstract: We describe the laser coagulation of the prostate using a conventional bare fiber inserted in a modified Albarran bridge which presents at the distal tip, a newly designed gold-plated reflector, connected by a deflecting mechanism. This allows delivery of laser energy (40 - 80 W) by direct reflection of the Nd:YAG laser light, an angularity more accentuated compared with other systems. Transurethral laser coagulation was performed on 25 patients for prostatic obstruction benign prostatic hyperplasia (BPH) and 6 selected patients for carcinoma of the prostate (December 91 - January 93). Patient selection (BPH) was limited to median lobe (range 50 - 55 years), small prostates, older and high-risk patients. Successful results were noted in 20 of the 25 cases of BPH group (80%). A significant reduction of obstructive symptoms was associated with an increase of maximal a medium flow rates. In the early prostate cancer group, the method has resulted in 3 patients with no evidence of disease, despite repeated biopsy, biochemical, and clinical investigations (PSA range level $GRT 20 ng/ml to $LS 0.5 ng/ml at one year). The results are encouraging at this stage. !13
机译:摘要:我们描述了一种使用插入到改良的Albarran桥中的常规裸光纤对前列腺进行激光凝结的方法,该桥位于远端,这是一种新设计的镀金反射器,通过偏转机构连接。这样可以通过Nd:YAG激光的直接反射来传递激光能量(40-80 W),与其他系统相比,其角度更加突出。经尿道激光凝结治疗前列腺癌良性前列腺增生(BPH)的25例患者和前列腺癌的6例选定的患者(91年12月至93年1月)。患者选择(BPH)仅限于中叶(50-55岁),前列腺小,年龄较大和高风险患者。 BPH组25例中有20例(80%)取得成功的结果。阻塞症状的明显减轻与最大流速的增加有关。在早期的前列腺癌组中,尽管进行了多次活检,生化和临床研究(一年中PSA范围从$ GRT 20 ng / ml到$ LS 0.5 ng / ml的PSA范围水平),该方法仍导致3例患者无疾病迹象。 。在这一阶段的结果令人鼓舞。 !13

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号